Published in Pediatr Infect Dis J on June 01, 1995
Laboratory diagnosis of pertussis: state of the art in 1997. J Clin Microbiol (1997) 1.84
Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children. Immunology (1998) 1.75
Cell-mediated immune responses in four-year-old children after primary immunization with acellular pertussis vaccines. Infect Immun (1999) 1.25
Evaluation of a tetraplex microsphere assay for Bordetella pertussis antibodies. Clin Vaccine Immunol (2006) 1.24
Pertussis vaccine: a critique. Pediatr Infect Dis J (2009) 0.91
Differential T- and B-cell responses to pertussis in acellular vaccine-primed versus whole-cell vaccine-primed children 2 years after preschool acellular booster vaccination. Clin Vaccine Immunol (2013) 0.88
Seroprevalence of pertussis in China: need to improve vaccination strategies. Hum Vaccin Immunother (2013) 0.84
Factors influencing the spread of pertussis in households. Eur J Pediatr (1998) 0.83
Toward a new vaccine for pertussis. Proc Natl Acad Sci U S A (2014) 0.83
Serum IgA responses against pertussis proteins in infected and Dutch wP or aP vaccinated children: an additional role in pertussis diagnostics. PLoS One (2011) 0.81
Laboratory Diagnosis of Pertussis. Clin Microbiol Rev (2015) 0.81
Opsonophagocytic activity and other serological indications of Bordetella pertussis infection in military recruits in Norway. Clin Vaccine Immunol (2007) 0.79
Age related differences in dynamics of specific memory B cell populations after clinical pertussis infection. PLoS One (2014) 0.77
Comparison of Western immunobloting to an enzyme-linked immunosorbent assay for the determination of anti-Bordetella pertussis antibodies. Clin Vaccine Immunol (2011) 0.75
Immune responses to pertussis antigens in infants and toddlers after immunization with multicomponent acellular pertussis vaccine. Clin Vaccine Immunol (2014) 0.75
A toxoid vaccine for pertussis as well as diphtheria? Lessons to be relearned. Lancet (1996) 4.30
Scandinavian model for eliminating measles, mumps, and rubella. Br Med J (Clin Res Ed) (1984) 3.25
Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report. N Engl J Med (1987) 2.83
Invasive pneumococcal infections: incidence, predisposing factors, and prognosis. Rev Infect Dis (1985) 2.26
Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina. Infect Immun (1997) 2.05
Comparison of broad-range bacterial PCR and culture of cerebrospinal fluid for diagnosis of community-acquired bacterial meningitis. Clin Microbiol Infect (2007) 2.05
Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis. J Infect Dis (2000) 2.04
Haemophilus ducreyi, a cytotoxin-producing bacterium. Infect Immun (1992) 1.86
Difference in structure between type b and nontypable Haemophilus influenzae populations. Infect Immun (1986) 1.84
A placebo-controlled trial of a pertussis-toxoid vaccine. N Engl J Med (1995) 1.78
Vaccination programme for eradication of measles, mumps, and rubella. Lancet (1982) 1.74
Evaluation of PCR for diagnosis of Bordetella pertussis and Bordetella parapertussis infections. J Clin Microbiol (1998) 1.68
Monoclonal antibodies against gastrointestinal tumour-associated antigens isolated as monosialogangliosides. Int Arch Allergy Appl Immunol (1983) 1.67
The Haemophilus ducreyi cytolethal distending toxin induces cell cycle arrest and apoptosis via the DNA damage checkpoint pathways. J Biol Chem (2000) 1.64
History of whooping cough in nonvaccinated Swedish children, related to serum antibodies to pertussis toxin and filamentous hemagglutinin. J Pediatr (1990) 1.53
Maturation indicators and the pubertal growth spurt. Am J Orthod (1982) 1.53
The cytolethal distending toxin from the chancroid bacterium Haemophilus ducreyi induces cell-cycle arrest in the G2 phase. J Clin Invest (1999) 1.52
Parapertussis infection followed by pertussis infection. Lancet (1994) 1.49
Etiology of community-acquired pneumonia in children based on antibody responses to bacterial and viral antigens. Pediatr Infect Dis J (1989) 1.48
Protective levels of serum antibodies stimulated in infants by two injections of Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugate. J Pediatr (1989) 1.46
Height and height velocity in early, average and late maturers followed to the age of 25: a prospective longitudinal study of Swedish urban children from birth to adulthood. Ann Hum Biol (1991) 1.44
Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis. Clin Infect Dis (1999) 1.39
Etiology of community-acquired pneumonia in patients requiring hospitalization. Eur J Clin Microbiol (1985) 1.39
GroEL heat shock protein of Haemophilus ducreyi: association with cell surface and capacity to bind to eukaryotic cells. Infect Immun (1998) 1.32
Local and systemic antibody responses to dextran-cholera toxin B subunit conjugates. Infect Immun (1995) 1.32
Detection by monoclonal antibody of carbohydrate antigen CA 50 in serum of patients with carcinoma. Br Med J (Clin Res Ed) (1984) 1.31
Application of multilocus enzyme gel electrophoresis to Haemophilus influenzae. Infect Immun (1986) 1.30
Diagnosis of pneumonia by cultures, bacterial and viral antigen detection tests, and serology with special reference to antibodies against pneumococcal antigens. J Infect Dis (1991) 1.27
Inhibition of attachment of Streptococcus pneumoniae and Haemophilus influenzae by human milk and receptor oligosaccharides. J Infect Dis (1986) 1.27
Effect of cefoperazone on faecal flora. J Antimicrob Chemother (1983) 1.26
Clinical, metabolic, and antibody responses of adult volunteers to an investigational vaccine composed of pertussis toxin inactivated by hydrogen peroxide. J Pediatr (1988) 1.25
Cellular internalization of cytolethal distending toxin from Haemophilus ducreyi. Infect Immun (2000) 1.24
The role of different protein components from the Haemophilus ducreyi cytolethal distending toxin in the generation of cell toxicity. Microb Pathog (2001) 1.24
Ceftazidime: pharmacokinetics in patients and effects on the renal function. J Antimicrob Chemother (1982) 1.22
Serotypes and clinical manifestations of invasive group B streptococcal infections in western Sweden 1998-2001. Clin Microbiol Infect (2004) 1.20
Incidence, predisposing factors and manifestations of invasive Haemophilus influenzae infections in adults. Eur J Clin Microbiol (1984) 1.20
Method for testing adherence of Haemophilus influenzae to human buccal epithelial cells. Eur J Clin Microbiol (1985) 1.20
Clinical characteristics of nephropathia epidemica in Sweden: prospective study of 74 cases. Rev Infect Dis (1990) 1.16
Etiology of community-acquired pneumonia in out-patients. Eur J Clin Microbiol (1986) 1.16
Clinical and immunologic responses to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18- to 23-month-old children. J Pediatr (1988) 1.14
Skeletal stages of the hand and wrist as indicators of the pubertal growth spurt. Acta Odontol Scand (1980) 1.13
Haemophilus influenzae meningitis in Sweden 1981-1983. Arch Dis Child (1987) 1.13
The somatic development of children in a swedish urban community. Acta Paediatr Scand Suppl (1976) 1.13
Swedish experience of two dose vaccination programme aiming at eliminating measles, mumps, and rubella. Br Med J (Clin Res Ed) (1987) 1.12
Use of serology to diagnose pneumonia caused by nonencapsulated Haemophilus influenzae and Moraxella catarrhalis. J Infect Dis (1994) 1.12
VI. Somatic pubertal development. Acta Paediatr Scand Suppl (1976) 1.10
Symptomatic treatment of acute infectious diarrhoea: loperamide versus placebo in a double-blind trial. J Infect (1986) 1.08
Efficacy of a monocomponent pertussis toxoid vaccine after household exposure to pertussis. J Pediatr (1997) 1.08
Systemic and mucosal immune responses in mice after mucosal immunization with group B streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate vaccine. Infect Immun (2000) 1.07
Mortality and morbidity from invasive bacterial infections during a clinical trial of acellular pertussis vaccines in Sweden. Pediatr Infect Dis J (1988) 1.07
Susceptibility of Bordetella pertussis to doxycycline, cinoxacin, nalidixic acid, norfloxacin, imipenem, mecillinam and rifampicin. J Antimicrob Chemother (1985) 1.06
Environmental contamination leading to false-positive polymerase chain reaction for pertussis. Pediatr Infect Dis J (1994) 1.06
Incidence and geographic distribution of serologically verified cases of nephropathia epidemica in Sweden. Am J Epidemiol (1988) 1.05
Serotypes and clinical manifestations of group B streptococcal infections in western Sweden. Clin Microbiol Infect (2000) 1.04
Septicaemia and meningitis in neonates and during early infancy in the Göteborg area of Sweden. Acta Paediatr (2002) 1.03
I. physical growth from birth to 16 years and longitudinal outcome of the study during the same age period. Acta Paediatr Scand Suppl (1976) 1.03
Cytotoxin production in 100 strains of Haemophilus ducreyi from different geographic locations. FEMS Microbiol Lett (1995) 1.02
Whooping cough in adults. Br Med J (Clin Res Ed) (1981) 1.02
Incidence and etiology of neonatal septicaemia and meningitis in western Sweden 1975-1986. Acta Paediatr Scand (1990) 1.02
Characterization of the serum antibody response to the capsular polysaccharide of Haemophilus influenzae type b in children with invasive infections. J Infect Dis (1992) 1.01
The impact of Haemophilus ducreyi cytolethal distending toxin on cells involved in immune response. Microb Pathog (2001) 1.01
Long-term treatment with corticosteroids/ACTH in asthmatic children. IV. Skeletal maturation. Acta Paediatr Scand (1986) 1.00
Counterimmunoelectrophoresis of sputum and blood for the diagnosis of chest infections caused by pneumococci or Haemophilus influenzae. Scand J Infect Dis (1979) 1.00
Prevalence of cdtABC genes encoding cytolethal distending toxin among Haemophilus ducreyi and Actinobacillus actinomycetemcomitans strains. J Med Microbiol (2001) 1.00
Menarche and voice change as indicators of the pubertal growth spurt. Acta Odontol Scand (1980) 1.00
Quantitative nephrotoxicity of gentamicin in nontoxic doses. J Infect Dis (1980) 0.99
Antibody response to pertussis toxin in patients with clinical pertussis measured by enzyme-linked immunosorbent assay. Eur J Clin Microbiol Infect Dis (1988) 0.98
Mass vaccination of children with pertussis toxoid--decreased incidence in both vaccinated and nonvaccinated persons. Clin Infect Dis (2001) 0.98
Dental development, dental age and tooth counts. Angle Orthod (1985) 0.97
Effect of trimethoprim on serum creatinine in patients with acute cystitis. J Antimicrob Chemother (1986) 0.97
Prediction of glomerular filtration rate from serum creatinine, age, sex and body weight. Acta Med Scand (1987) 0.96
Incidence, aetiology, and prognosis of acute epiglottitis in children and adults in Sweden. Scand J Infect Dis (1996) 0.96
Characterisation of invasive group B streptococci based on investigation of surface proteins and genes encoding surface proteins. Clin Microbiol Infect (2007) 0.95
Parapertussis and pertussis: differences and similarities in incidence, clinical course, and antibody responses. Int J Infect Dis (1999) 0.95
Response and decline of serum IgG antibodies to pertussis toxin, filamentous hemagglutinin and pertactin in children with pertussis. Scand J Infect Dis (1995) 0.94